Home›Companies›Biotech & Pharma›PhenoVista BioSciences

PhenoVista BioSciences, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 11, 2023·Suggest an edit

About PhenoVista BioSciences

PhenoVista BioSciences is a private company based in San Diego, California, incorporated in 2022 in Delaware. It has reported $3,000,000 raised in one offering on Form D since January 2023. Its chief executive is James Evans.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 7, 2022Jan 11, 2023$3,000,000fully sold1$3.0MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on PhenoVista BioSciences's Form D filed Jan 11, 2023.

BC
Brian Conn
Executive officer
JE
James Evans
Chief Executive Officer and director
AE
Anthony Essex
Executive officer and director

Sources

  1. SECPhenoVista BioSciences, Inc. filing history